Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

5.41

+0.28 (5.46%)

At close: Mar 9, 2026, 4:00 PM EDT

5.39

-0.02 (-0.37%)

After-hours: Mar 9, 2026, 6:43 PM EDT

Iovance Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	163.08	115.69	114.89	231.73	78.23
Short-Term Investments	133.9	208.09	164.98	240.11	426.18
Cash & Short-Term Investments	296.98	323.78	279.87	471.85	504.41
Cash Growth	-8.28%	15.69%	-40.69%	-6.46%	-19.86%
Accounts Receivable	82.45	69.34	0.15	-	-
Inventory	51.68	51.52	10.37	-	-
Other Current Assets	11.58	12.38	17.46	7.27	3.55
Total Current Assets	442.69	457.02	307.85	479.12	507.96
Net Property, Plant & Equipment	177.01	164.28	176.55	178.25	169.92
Other Intangible Assets	279.32	282.4	229.26	-	-
Long-Term Investments	-	-	-	-	91.59
Other Long-Term Assets	14.15	6.73	66.7	6.62	7.87
Total Assets	913.17	910.43	780.35	663.98	777.33
Accounts Payable	22.16	27.51	33.12	26.6	27.38
Accrued Expenses	111.16	81.94	69.41	52.3	56.77
Short-Term Debt	1	-	-	-	-
Current Portion of Leases	4.04	12.9	7.78	12.59	5.06
Total Current Liabilities	138.36	122.34	110.31	91.49	89.2
Long-Term Debt	-	1	1	1	1
Long-Term Leases	44.4	44.37	67.09	71.86	65.47
Other Long-Term Liabilities	31.83	32.32	17.35	-	-
Total Long-Term Liabilities	76.23	77.68	85.43	72.86	66.47
Total Liabilities	214.59	200.02	195.74	164.34	155.67
Preferred Stock	0	0	0	0	0
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	3,458	3,096	2,594	2,069	1,795
Accumulated Other Comprehensive Income	16.44	-1.05	2.53	-0.9	-0.6
Retained Earnings	-	-	-2,012	-1,568	-1,172
Shareholders' Equity	3,474	3,095	584.61	499.64	621.66
Total Liabilities & Equity	913.17	910.43	780.35	663.98	777.33
Total Debt	49.44	58.26	75.86	85.45	71.53
Net Cash (Debt)	247.54	265.52	204.01	386.4	432.88
Net Cash Growth	-6.77%	30.15%	-47.20%	-10.74%	-25.08%
Net Cash Per Share	0.69	0.92	0.87	2.43	2.82
Book Value	3,474	3,095	584.61	499.64	621.66
Book Value Per Share	9.72	10.68	2.49	3.14	4.05
Tangible Book Value	3,195	2,813	355.36	499.64	621.66
Tangible Book Value Per Share	8.94	9.70	1.51	3.14	4.05

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q